MCM
RMD icon

Manchester Capital Management’s ResMed RMD Stock Holding History

Manchester Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Sell
529
-14
-3% -$2.9K 0.01% 383
2026
Q1 		$122K Buy
543
+16
+3% +$3.99K 0.02% 344
2025
Q4 		$127K Buy
527
+6
+1% +$1.53K 0.02% 332
2025
Q3 		$143K Sell
521
-12
-2% -$3.28K 0.02% 365
2025
Q2 		$138K Sell
533
-212
-28% -$50.6K 0.02% 405
2025
Q1 		$167K Buy
745
+28
+4% +$6.54K 0.02% 359
2024
Q4 		$164K Buy
717
+211
+42% +$50.8K 0.02% 363
2024
Q3 		$124K Buy
506
+15
+3% +$3.35K 0.01% 408
2024
Q2 		$94K Buy
491
+14
+3% +$2.84K 0.01% 425
2024
Q1 		$94.5K Buy
477
+9
+2% +$1.65K 0.01% 411
2023
Q4 		$80.5K Buy
468
+50
+12% +$7.68K 0.01% 375
2023
Q3 		$61.8K Sell
418
-1,746
-81% -$316K 0.01% 393
2023
Q2 		$473K Sell
2,164
-561
-21% -$125K 0.06% 178
2023
Q1 		$597K Buy
2,725
+289
+12% +$62.7K 0.08% 160
2022
Q4 		$507K Buy
2,436
+2,428
+30,350% +$533K 0.07% 156
2022
Q3 		$2K Hold
8
– – ﹤0.01% 680
2022
Q2 		$2K Buy
8
+2
+33% +$426 ﹤0.01% 733
2022
Q1 		$1K Hold
6
– – ﹤0.01% 970
2021
Q4 		$2K Sell
6
-2
-25% -$519 ﹤0.01% 867
2021
Q3 		$2K Buy
+8
New +$2.19K ﹤0.01% 882
2021
Q1 		– Sell
-14
Closed -$3K – 758
2020
Q4 		$3K Buy
14
+8
+133% +$1.59K ﹤0.01% 579
2020
Q3 		$1K Buy
+6
New +$1.11K ﹤0.01% 521
2015
Q1 		– Sell
-4,685
Closed -$263K – 809
2014
Q4 		$263K Hold
4,685
– – 0.03% 295
2014
Q3 		$231K Hold
4,685
– – 0.03% 315
2014
Q2 		$237K Hold
4,685
– – 0.03% 324
2014
Q1 		$209K Sell
4,685
-250
-5% -$11.2K 0.03% 330
2013
Q4 		$232K Hold
4,935
– – 0.04% 299
2013
Q3 		$261K Hold
4,935
– – 0.04% 274
2013
Q2 		$223K Buy
+4,935
New +$234K 0.04% 280

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Manchester Capital Management's RMD Position: Q2 2026 in Review

Manchester Capital Management reduced its ResMed (RMD) stake by 2.6% in Q2 2026, selling an estimated $2.9K and leaving 529 shares worth $103K. The position accounts for 0.01% of the portfolio, ranked #383.

Manchester Capital Management first reported a position in RMD in Q2 2013 and has held it in 29 quarters since. The position peaked at $597K in Q1 2023. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Manchester Capital Management held 529 shares of ResMed worth $103K as of Q2 2026.
  • Manchester Capital Management sold 14 ResMed shares in Q2 2026, an estimated $2.9K.
  • ResMed made up 0.01% of Manchester Capital Management's portfolio in Q2 2026, its #383 holding.
  • Manchester Capital Management first reported a position in ResMed in Q2 2013 and has held it in 29 quarters since.
  • Manchester Capital Management's ResMed position peaked at $597K in Q1 2023.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.